https://www.frontiersin.org/journals/nephrology RSS Feed for Frontiers in Nephrology | New and Recent Articles en-us Frontiers Feed Generator,version:1 2026-04-16T14:24:23.728+00:00 60 https://www.frontiersin.org/articles/10.3389/fneph.2026.1776371 https://www.frontiersin.org/articles/10.3389/fneph.2026.1776371 2026-04-07T00:00:00Z Original Research Delphine BaillyMaher AbdessaterRamy Touma SawayaBenoit BarrouSarah Drouin 50%). During the study period, 5,214 platform events and more than 4,000 secure messages were recorded, reflecting sustained engagement. APNs required a mean workload of 3 hours per day to manage all active users on a daily basis.ConclusionTelemonitoring after kidney transplantation is feasible and well accepted, improving perceived access to care and enhancing patient reassurance without measured clinical outcome differences. Adherence is driven primarily by organizational and technological factors rather than patient characteristics. APNs play a central role in ensuring continuity of care, triaging data, and maintaining patient engagement. Future studies should evaluate clinical outcomes and cost-effectiveness to support broader implementation.]]> https://www.frontiersin.org/articles/10.3389/fneph.2026.1773415 https://www.frontiersin.org/articles/10.3389/fneph.2026.1773415 2026-03-26T00:00:00Z Mini Review Priti MeenaAisha Batool https://www.frontiersin.org/articles/10.3389/fneph.2026.1762265 https://www.frontiersin.org/articles/10.3389/fneph.2026.1762265 2026-03-19T00:00:00Z Case Report Phuong-Thu T. PhamPhuong-Chi T. Pham https://www.frontiersin.org/articles/10.3389/fneph.2026.1608421 https://www.frontiersin.org/articles/10.3389/fneph.2026.1608421 2026-03-12T00:00:00Z Original Research Sophie MolholmAna A. FranciscoDouwe J. HorsthuisTringa LecajDennis CreginChloe BrittenhamJohn J. Foxe https://www.frontiersin.org/articles/10.3389/fneph.2026.1734903 https://www.frontiersin.org/articles/10.3389/fneph.2026.1734903 2026-03-12T00:00:00Z Original Research Sonia MehrotraRaj Kumar SharmaRakesh KapoorRajesh Kumar JaiswalRohit Kapoor 5,000 and in the context of ABO incompatibility, may predispose to AMR. DQ DSAs with lower MFI require vigilant monitoring due to the risk of post-transplant rebound. ATLG-based induction was associated with low rejection incidence and favorable short-term outcomes.]]> https://www.frontiersin.org/articles/10.3389/fneph.2026.1772736 https://www.frontiersin.org/articles/10.3389/fneph.2026.1772736 2026-03-03T00:00:00Z Case Report Andreia Rita HenriquesJoão VendaEmanuel FerreiraNuno OliveiraHelena Sá 1g/24 h and hypoalbuminemia, the patient received OBZ (1 g × 2 doses, two weeks apart). Two months later, she achieved complete remission (proteinuria 0.2 g/24 h, serum albumin 3.7 g/dL), with sustained B-cell depletion and no adverse events. A repeat administration of OBZ (1 g) was performed 10 months later due to B-cell repopulation, rising proteinuria (0.6 g/24 h), and mild hypoalbuminemia (serum albumin 3.4 g/dL), successfully re-inducing complete remission (proteinuria 0.2 g/24 h, serum albumin 3.8 g/dL).DiscussionThis case illustrates the potential of OBZ as an effective therapeutic option in podocytopathies with RTX inadequate response. The superior efficacy of OBZ may result from enhanced antibody-dependent cellular cytotoxicity, depletion of tissue-resident B cells, and reduced immunogenicity compared with RTX. OBZ may thus offer an alternative in refractory MCD/FSGS.]]> https://www.frontiersin.org/articles/10.3389/fneph.2026.1648950 https://www.frontiersin.org/articles/10.3389/fneph.2026.1648950 2026-02-27T00:00:00Z Original Research Danny Thieny TaingBruno VogtLaila-Yasmin Mani https://www.frontiersin.org/articles/10.3389/fneph.2026.1707170 https://www.frontiersin.org/articles/10.3389/fneph.2026.1707170 2026-02-20T00:00:00Z Review Diksha MakkarDiksha GakharAruna Rakha https://www.frontiersin.org/articles/10.3389/fneph.2026.1747678 https://www.frontiersin.org/articles/10.3389/fneph.2026.1747678 2026-02-13T00:00:00Z Review Edward J. FilipponeJohn L. Farber https://www.frontiersin.org/articles/10.3389/fneph.2026.1735217 https://www.frontiersin.org/articles/10.3389/fneph.2026.1735217 2026-02-09T00:00:00Z Systematic Review Fakhria Al RashdiCeline TabcheZeenah AtwanHamed Al-QanubiSamiya Al KhaldiNasrin Al-ZadjaliSalman Rawaf https://www.frontiersin.org/articles/10.3389/fneph.2026.1730580 https://www.frontiersin.org/articles/10.3389/fneph.2026.1730580 2026-02-06T00:00:00Z Case Report Michael Hieu TruongVanessa Quynh TranSpencer Doan TranCalvin Tuan NguyenPhuong Chi PhamQuynh Giao Pham https://www.frontiersin.org/articles/10.3389/fneph.2026.1718842 https://www.frontiersin.org/articles/10.3389/fneph.2026.1718842 2026-02-04T00:00:00Z Original Research Katharina KonzettSabrina NeururerMartin Tiefenthaler 50%. PVD ≥ 0.25 cm was associated with recipient age and moderate tubular atrophy (ct). RI showed no association with histopathologic lesions. These findings identify POV and PVD as non-invasive markers of chronic injury in kidney allografts, highlighting their potential adjunctive role in detecting parenchymal damage. As such, CCDS may support – but not replace – biopsy, which remains essential for establishing a definitive diagnosis in graft dysfunction.]]> https://www.frontiersin.org/articles/10.3389/fneph.2025.1719394 https://www.frontiersin.org/articles/10.3389/fneph.2025.1719394 2026-02-03T00:00:00Z Original Research Will W. Minuth https://www.frontiersin.org/articles/10.3389/fneph.2025.1749827 https://www.frontiersin.org/articles/10.3389/fneph.2025.1749827 2026-01-27T00:00:00Z Review Xiao FuYiting ShuYun Zhang https://www.frontiersin.org/articles/10.3389/fneph.2025.1681679 https://www.frontiersin.org/articles/10.3389/fneph.2025.1681679 2026-01-21T00:00:00Z Original Research Pringgodigdo NugrohoJeremia SiregarTri Juli Edi TariganKuntjoro HarimurtiAida LydiaEvy YunihastutiPradana SoewondoHamzah Shatri 0.3). Predictive performance was poor: AUCs for eGFR decline were 0.504 (podocin), 0.512 (nephrin), and 0.523 (PNR). For albuminuria progression, AUCs were 0.563, 0.524, and 0.544, respectively. Subgroup analyses similarly showed no significant predictive value.DiscussionThese results suggest that single baseline measurements of podocin, nephrin, or PNR may have limited short-term prognostic value in DKD. However, the presence of these markers, even in patients with only moderate disease, supports their role as early indicators of podocyte stress.ConclusionWhile urinary podocyte-associated proteins reflect early glomerular injury, their utility as stand-alone prognostic biomarkers over a one-year period may be limited. Larger longitudinal studies assessing biomarker trajectories and integrating additional molecular markers are warranted.]]> https://www.frontiersin.org/articles/10.3389/fneph.2025.1582775 https://www.frontiersin.org/articles/10.3389/fneph.2025.1582775 2026-01-20T00:00:00Z Original Research Mohamed FakhfakhTaha LassouedFiras NouriNizar Ibn El MechriAla DalySalem AbdessalemSouad FerjaniSami Milouchi 100ml (p=0.015) and the presence of a two-vessel coronary artery disease (p=0.008). In multivariate analysis, severe endothelial dysfunction (OR = 5.46; p = 0.014), rescue PCI (OR = 5.77; p = 0.04) and contrast medica volume equal or over 140 ml (OR = 6.96; p = 0.036) were independent risk factors of CA-AKI. We found that pre- and post-hydration with isotonic saline solution and that patients whose baseline treatment includes statins, were significantly prevented from developing CA-AKI. (p=0.007 and 0.008 respectively).ConclusionOur study showed a significant association between the presence of severe endothelial dysfunction, assessed non-invasively by FTM, and the risk of developing CA-AKI. These results appear to be relevant considering that EQI is a low-cost, non-invasive and easily reproducible marker of endothelial dysfunction.]]> https://www.frontiersin.org/articles/10.3389/fneph.2025.1702475 https://www.frontiersin.org/articles/10.3389/fneph.2025.1702475 2026-01-14T00:00:00Z Case Report Mariel Hernandez-PérezDaniel Enos https://www.frontiersin.org/articles/10.3389/fneph.2025.1684004 https://www.frontiersin.org/articles/10.3389/fneph.2025.1684004 2026-01-14T00:00:00Z Mini Review Jorge Rico-FontalvoMaria Raad-SarabiaJuan Montejo HernándezTomas Rodríguez YánezLacides Rafael Caparroso RamosPaula Parra SánchezAna Alexandra Ovalle GomezJavier Jimenez QuinteroRodrido Daza-Arnedo https://www.frontiersin.org/articles/10.3389/fneph.2025.1691773 https://www.frontiersin.org/articles/10.3389/fneph.2025.1691773 2026-01-12T00:00:00Z Original Research Sarah S. MonshiHatoon M. AlamriAfnan M. AlmuaddiFatemah M. AlmutairiHala R. AljishiKhulud A. AlfakiMaram S. AlTurkiRayyan M. SaqahMohammed S. Aldossary https://www.frontiersin.org/articles/10.3389/fneph.2025.1744454 https://www.frontiersin.org/articles/10.3389/fneph.2025.1744454 2026-01-09T00:00:00Z Brief Research Report John J. SimNancy T. CannizzaroQiaoling ChenSasikiran NunnaMohit MathurCibele Pinto 5 ml min−1 1.73 m−2 per year). The composite kidney outcome occurred at 73.3 events per 1,000 patient-years, with a median time to event of 2.8 years and a median age at event of 46 years.ConclusionHispanic/Latinx patients with IgAN demonstrate rapid kidney function decline and early-onset kidney failure. These findings underscore the need for earlier detection and targeted management in this underserved group.]]>